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Serotype C and D of Clostridium botulinum produce botulinum
toxin complex (TC), which is comprised of botulinum neurotoxin,
nontoxic nonhemagglutinin, and hemagglutinins (HAs). The TC is
capable of aggregating equine erythrocytes via interaction
between one of the HAs, namely HA-33, and sugar chains on the
cell surface. This hemagglutination is inhibited by speciﬁc sugars.
In this data article, we used four TCs from serotype C and D strains.
The hemagglutination-inhibiting effects of 18 sugars and 8 glyco-
proteins were studied. The puriﬁed TC was mixed with the sugar
to enable binding of the sugar to the TC; then, the erythrocytes
were added to the mixture. Speciﬁc binding between the sugar and
TC resulted in inhibition of cell aggregation. Here, data illustrating
the inhibitory effects of various sugars and glycoproteins againstvier Inc. This is an open access article under the CC BY license
.jp (Y. Sagane).
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are presented.
& 2016 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biology
ore speciﬁc sub-
ject areaMicrobiologyype of data Table
ow data was
acquiredProtein puriﬁcation, SDS-PAGE, hemagglutination assay, and hemagglutina-
tion inhibition assayata format Raw
xperimental
factorsToxin complexes produced by four strains of C. botulinum were puriﬁed from
the culture media of each strain.xperimental
featuresInhibitory effects of sugars and glycoproteins against hemagglutination
induced by the toxin complex were assessed.ata source
locationAbashiri, Japanata accessibility Data are presented in this articleD
Value of the data
1. The data presented illustrate the speciﬁc inhibitory effect exerted by 18 sugars and 8 glycoproteins
on hemagglutination by the toxin complex (TC) of serotypes C and D of C. botulinum.
2. The results in this article indicate that two modes of hemagglutination mediated by the TCs of
C. botulinum serotypes C and D strains may be distinguished via the inhibitory proﬁles exerted by
the present sugars and glycoproteins.
3. The data in this article should be useful for elucidation of the mechanism underlying the recog-
nition of sugars by the TCs of C. botulinum serotypes C and D.1. Data
Here, we present data illustrating the inhibitory effects of 18 sugars and 8 glycoproteins (listed in
Table 1) on hemagglutination by L-TC, a complex of the botulinum neurotoxin (BoNT), nontoxic
nonhemagglutinin (NTNHA), and three types of hemagglutinin subcomponents (HA-70, HA-17, and
HA-33), produced by the C. botulinum serotype C strain Stockholm (C-St), Yoichi (C-Yoichi), D strain
CB-16 (D-CB16), and 1873 (D-1873).2. Experimental design
L-TC was puriﬁed from the culture of C. botulinum C-St [1], C-Yoichi [2], D-CB16 [3], and D-1873 [4]
as described in the cited studies. Of the L-TC components, the BoNT also binds to the cells via sugar-
recognition ability [5]. However, the residues essential for the sugar-recognition in the BoNT molecule
are covered with other components of the L-TC [6,7]; thus the cell binding of the L-TC dominantly
depend on the HA-33 components that exposed to the most outside of the molecule [7]. To date, it has
been shown that, in the serotypes C and D of C. botulinum, there are at least two types of L-TC
containing the HA-33 protein, that preferentially recognize sugar chains with sialic acid moieties
Table 1
Inhibitory effects on hemagglutination by C-St, C-Yoichi, D-CB16, and D-1873 L-TC.
Sugars or glycoproteins C-St D-CB16 C-Yoichia D-1873a
D-glucose – – þ þ
D-mannose – – þ þ
Galactose – – þ þ
N-acetyl-D-glucosamine – – – –
Methyl-α-D-mannoside – – þ þ
L-Fucose – – þ þ
Xylose – – – –
Fructose – – þ þ
Rhamnose – – þ þ
N-Acetyl-D-galactosamine – – þ þ
Sucrose – – þ þ
N-Acetylneuraminic acid þ þ – –
Maltose – – þ þ
Cellobiose – – þ þ
Lactose – – þ þ
Chitin oligomer – – – –
N-Acetyllactosamine – – þ þ
Chitobiose – – – –
Bovine fetuin – – – –
Asialofetuin – – þ þ
Ovomucoid – – – –
Ovoalbumin – – – –
Human transferrin – – – –
Horseradish peroxidase – – – –
Yeast invertase – – þ þ
Human α1-Acid glycoprotein þ þ – –
a Neuraminidase-treated erythrocyte was used.
Y. Sagane et al. / Data in Brief 9 (2016) 413–416 415(of C-St and D-CB16) or galactose moieties (of C-Yoichi and D-1873) at their termini [2,4]. Previous
studies have shown that C-St and D-CB16 L-TCs exert the hemagglutination activity against equine
erythrocytes, whereas C-Yoichi and D-1873 L-TCs exhibited no, or very low, hemagglutination titer
against equine erythrocytes. However, C-Yoichi and D-1873 L-TCs were found to exhibit hemagglu-
tination titer against equine erythrocytes treated with neuraminidase [2,4]. Therefore, normal ery-
throcytes were used to study hemagglutination by C-St and D-CB16, and neuraminidase-treated
erythrocytes were used to study hemagglutination by the C-Yoichi and D-1873 strains.3. Materials and methods
3.1. SDS-PAGE
SDS-PAGE was performed as described by Laemmli [8], by using a 13.6% polyacrylamide gel with
2-mercaptoethanol.
3.2. Preparation of equine erythrocyte suspension
Erythrocytes in deﬁbrinated equine blood (Kojin Bio, Sakaido, Saitama, Japan) were collected by
centrifugation ( 1000 g, 5 min, 4 °C) (TOMY GRX-220, Tomy Seiko Co., Ltd., Tokyo, Japan) and rinsed
with 0.15 M phosphate buffer, pH 7.0. Suspension of the erythrocytes (1%) was prepared with the
same buffer. Erythrocytes were treated with Clostridium perfringens neuraminidase (Sigma-Aldrich).
Neuraminidase (0.5 U) was added to a 10% equine erythrocyte suspension, and the mix was incubated
at 37 °C for 1 h. Treated erythrocytes were collected, rinsed, and suspended in 0.15 M phosphate
buffer (pH 7.0) to create a 1% suspension.
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Hemagglutination assay was performed by the microtitration method, using a multiwell titer plate
(Nunc A/S, Roskilde, Denmark). Samples (35 ml) of each preparation (100 mg/ml) were diluted in serial
two-fold steps with 0.15 M phosphate buffer (pH 7.0) and mixed with an equal volume of a 1% equine
erythrocyte suspension. After incubation at 20–25 °C for 2 h, the reciprocal hemagglutination titer
was determined as 2n.
For the inhibitory test, sugars (D-glucose, D-mannose, galactose, N-acetyl-D-glucosamine, methyl-
α-D-mannoside, L-fucose, xylose, fructose, rhamnose, N-acetyl-D-galactosamine, sucrose, N-acet-
ylneuraminic acid, maltose, cellobiose, lactose, chitin oligomers, N-acetyllactosamine, and chitobiose)
and glycoproteins (bovine fetuin, asialofetuin, ovomucoid, ovoalbumin, human transferrin, horse-
radish peroxidase, yeast invertase, and human α1-acid glycoprotein) were used in this study. The L-TC
solution (10 ml, titer 2) was incubated with an equal volume of sugar or glycoprotein solution (ﬁnal
concentration of 5 mg/ml), at room temperature, for 1 h. Thereafter, the solution was incubated with
20 ml of equine erythrocyte suspension (1%) at 37 °C for 1 h.Acknowledgments
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